Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

The Westin Boston Seaport District

Mar 02, 2026 11:00 AM - Mar 04, 2026 12:30 PM

425 Summer Street, Boston, MA 02210, USA

Medical Affairs and Scientific Communications Forum

The longest running neutral forum cultivating interdepartmental relationships in medical affairs.

Early Bird Rates End

DAYS

HOURS

MINUTES

SECONDS

Session 9 Track 2: Clear, Compliant, Compelling: Elevating Medical Device Communication Across Scientific and Commercial Channels

Session Chair(s)

Jenny  Boyar, PhD

Jenny Boyar, PhD

Principal Medical Writer

AbbVie, United States

As the healthcare ecosystem rapidly evolves, the medical device sector continues to push the boundaries of innovation, introducing technologies that transform patient care, diagnostics, and health outcomes. With this pace of advancement comes an increasing need for clear, accurate, and compliant communication across scientific, regulatory, and commercial channels.

This session will explore best practices and emerging trends in medical and scientific communications for medical devices, including how to effectively translate complex data into meaningful narratives for diverse stakeholders such as healthcare professionals, regulators, payers, and patients. Panelists will discuss the challenges of balancing innovation with compliance, the role of cross-functional collaboration, and the impact of digital transformation and AI on communication strategies.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify effective approaches for communicatinge the clinical and real-world value of medical devices with clarity and integrity
  • Discuss strategies for ensuring scientific accuracy and regulatory alignment in device communications
  • Describe the evolving expectations of stakeholders in an increasingly digital and data-driven healthcare landscape

Speaker(s)

Anmol  Limaye

Borrowing from Devices: Leveraging Risk-Based Frameworks and AI to Accelerate Readiness for EU Pharma Regulatory Change

Anmol Limaye

Alcon, United States

Manager

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.